MedTrace Logo

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

NCT06181656 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-05-20

No results posted yet for this study

Summary

To learn how radiation treatment may affect your responses to vaccines against pneumonia.

Conditions

  • Pneumococcal Vaccine
  • Esophageal Cancer
  • Lymphopenia
  • Chemoradiation

Interventions

BIOLOGICAL

Pneumonia vaccine

Given by SC

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Steven H Lin, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2027-07-04
Completion
2027-07-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06181656 on ClinicalTrials.gov